THE CHALLENGE OF LIPID-MODIFYING THERAPIES IN THE ACHIEVEMENT OF OPTIMAL LDL-C LEVELS IN HIGH AND VERY HIGH CV RISK PATIENTS: STILL AN OPEN QUESTION

被引：0
|
作者：
Rossi, I. [1 ]
D'Ardes, D. [1 ]
Bucciarelli, B. [2 ]
Bianco, F. [3 ]
Troiano, F. [1 ]
Vizzarri, P. [1 ]
Caporale, M. [1 ]
Cipollone, F. [1 ]
Bucci, M. [1 ]
机构：
[1] Univ G dAnnunzio, Med & Aging Sci, Chieti, Italy
[2] Azienda Osped Univ Osped Riuniti, Pediat, Ancona, Italy
[3] Azienda Osped Univ Osped Riuniti, Cardiol, Ancona, Italy
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP645
引用
收藏
页码：E306 / E306
页数：1
相关论文
共 47 条
  • [1] Prevalence of reaching target low-density lipoprotein cholesterol (LDL-C) in very high -risk patients using high intensity lipid-modifying therapy
    Khader, A. Omar
    Van der Brug, S.
    Liem, A.
    Hamer, B.
    Groenemeijer, B.
    Martens, F.
    Alings, M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1412 - 1412
  • [2] Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands
    Kuiper, Josephina G.
    Sanchez, Robert J.
    Houben, Eline
    Heintjes, Edith M.
    Penning-van Beest, Fernie J. A.
    Khan, Irfan
    van Riemsdijk, Melanie
    Herings, Ron M. C.
    CLINICAL THERAPEUTICS, 2017, 39 (04) : 819 - 827
  • [3] LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A VERY HIGH CARDIOVASCULAR RISK COHORT OF PATIENTS MANAGED BY GENERAL PRACTITIONERS IN ITALY
    Fanelli, F.
    Gazzi, L.
    Heiman, F.
    Peduto, I
    Pegoraro, V
    VALUE IN HEALTH, 2018, 21 : S96 - S97
  • [4] Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study
    Mostaza, J. M.
    Garcia-Ortiz, L.
    Tembra, M. A. Suarez
    Calle, P. Talavera
    Garcia, J. Chimeno
    Perez, V. Escolar
    Diaz-Diaz, J. L.
    Manzano-Espinosa, L.
    Catapano, A. L.
    Ray, K. K.
    Moya, G. Diaz
    Montoya, J. Pedro-Botet
    REVISTA CLINICA ESPANOLA, 2025, 225 (02): : 78 - 84
  • [5] Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD
    Kim, Ah-Ram
    Han, Ji Ye
    Kim, Minkyoung
    Lee, Hojoon
    Baek, Yeon-Hee
    Ahn, Imjin
    Kang, Hee Jun
    Oh, Ji Seon
    Kim, Ju Hyeon
    Kwon, Osung
    Jun, Tae Joon
    Kwon, Sun U.
    Kim, Young-Hak
    CARDIOLOGY AND THERAPY, 2025, 14 (01) : 101 - 115
  • [6] Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
    Yang, Ye Seul
    Lee, Seo Young
    Kim, Jung-Sun
    Choi, Kyung Mook
    Lee, Kang Wook
    Lee, Sang-Chol
    Cho, Jung Rae
    Oh, Seung-Jin
    Kim, Ji-Hyun
    Choi, Sung Hee
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (02) : 367 - 376
  • [7] ACHIEVEMENT OF LDL-C GOALS IN PATIENTS AT MODERATE TO VERY HIGH CARDIOVASCULAR RISK ON LIPID-LOWERING DRUG THERAPY (CEPHEUS II)
    Logunova, Natalia
    Gurina, Natalia
    Boytsov, Sergey
    ATHEROSCLEROSIS, 2017, 263 : E236 - E237
  • [8] ACHIEVEMENT OF LDL-C TARGETS IN CHINESE PATIENTS WITH VERY HIGH RISK ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RECEIVING INTENSIVE LIPID LOWERING THERAPY
    Cheng, Y.
    Dong, S.
    Shen, P.
    Sun, Y.
    Lin, H.
    Zhai, S.
    VALUE IN HEALTH, 2022, 25 (01) : S24 - S24
  • [9] LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A VERY HIGH CARDIOVASCULAR RISK COHORT OF STATIN INTOLERANT PATIENTS MANAGED BY GENERAL PRACTITIONERS IN ITALY
    Gazzi, L.
    Fanelli, F.
    Heiman, F.
    Di Filippo, A.
    Pegoraro, V
    VALUE IN HEALTH, 2018, 21 : S96 - S96
  • [10] FAVOURABLE IMPACT ON LIPID LEVELS OF INCREASING STATIN DOSE IN HIGH-RISK PATIENTS WITH VERY HIGH BASELINE LDL-C: RESULTS FROM VOYAGER
    Lundman, P.
    Palmer, M. K.
    Karlson, B. W.
    Barter, P. J.
    Nicholls, S. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 164 - 164
12345